The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Activation of the type I interferon system in primary Sjögren's syndrome: A possible etiopathogenic mechanism
Abstract
Objective: The etiopathogenesis of primary Sjögren's syndrome (SS) is largely unknown. In other autoimmune diseases, type I interferon (IFN) may play a pivotal role by triggering and sustaining the disease process. We therefore aimed to determine whether patients with primary SS had an activated type I IFN system. Methods: Salivary gland biopsy specimens and sera from patients with primary SS were investigated for the occurrence of IFNα‐producing cells and measurable IFNα levels, respectively. The ability of primary SS sera together with apoptotic or necrotic cells to induce IFNα production in normal peripheral blood mononuclear cells was examined. The IFNα inducer was characterized, and IFNα‐producing cells were identified. Clinical data were correlated with the IFNα‐inducing capacity of primary SS sera. Results: Numerous IFNα‐producing cells were detected in salivary gland biopsy specimens, despite low serum IFNα levels. Autoantibodies to RNA‐binding proteins, combined with material released by necrotic or late apoptotic cells, were potent inducers of IFNα production in plasmacytoid dendritic cells (PDCs). This appeared to be attributable to RNA‐containing immune complexes triggering PDCs by means of RNA and interaction with Fcγ receptor IIa. The IFNα‐inducing capacity of sera was associated with positive results of a labial salivary gland biopsy (focus score ≥1) and with dermatologic, hematologic, and pulmonary manifestations. Conclusion: Patients with primary SS have an activated type I IFN system. Although virus may initiate the production of IFN, the continued IFNα synthesis is caused by RNA‐containing immune complexes that activate PDCs to prolong IFNα production at the tissue level. This IFNα promotes the autoimmune process by a vicious circle–like mechanism, with increased autoantibody production and formation of more endogenous IFNα inducers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u · Cited by 882
Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Günther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1823 · Cited by 766
Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., & Jahnsen, F. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61689-6 · Cited by 730
Sjögren's syndrome. Proposed criteria for classification
Fox, R. I., Robinson, C. A., Curd, J. G., Kozin, F., & Howelly, F. V. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290501 · Cited by 682
Lövgren, T., Eloranta, M., Båve, U., Alm, G. V., & Rönnblom, L. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20254 · Cited by 552
Self-citationAutoantibodies in the diagnosis of systemicrheumatic diseases
von Mühlen, C. A., & Tan, E. M. (1995) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(95)80004-2 · Cited by 546
Activation of Autoreactive B Cells by CpG dsDNA
Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J., & Marshak-Rothstein, A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00323-6 · Cited by 521
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice
Santiago-Raber, M.-L., Baccala, R., Haraldsson, K. M., Choubey, D., Stewart, T. A., Kono, D. H., & Theofilopoulos, A. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021996 · Cited by 509
Salomonsson, S., Jonsson, M. V., Skarstein, K., Brokstad, K. A., Hjelmström, P., Wahren‐Herlenius, M., & Jonsson, R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11311 · Cited by 472
Bengtsson, A. A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., & Rönnblom, L. (2000) · Lupus · doi:10.1191/096120300674499064 · Cited by 464
Self-citationAutoimmunity after Alpha-Interferon Therapy for Malignant Carcinoid Tumors
Rönnblom, L. E., Alm, G. V., & Öberg, K. E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-178 · Cited by 455
Self-citationBåve, U., Magnusson, M., Eloranta, M.-L., Perers, A., Alm, G. V., & Rönnblom, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3296 · Cited by 380
Self-citationVallin, H., Perers, A., ALM, G. V., & Rönnblom, L. (1999) · PubMed · Cited by 284
Self-citationVallin, H., Perers, A., Alm, G. V., & Rönnblom, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6306 · Cited by 256
Self-citationVALLIN, H., BLOMBERG, S., ALM, G. V., CEDERBLAD, B., & RÖNNBLOM, L. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00772.x · Cited by 252
Self-citationCurrent evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy
Ioannou, Y., & Isenberg, D. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200007)43:7<1431::aid-anr3>3.0.co;2-e · Cited by 252
Vanbervliet, B., Bendriss-Vermare, N., Massacrier, C., Homey, B., de Bouteiller, O., Brière, F., Trinchieri, G., & Caux, C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020437 · Cited by 248
Akin, R. K., Kreller, A. J., & Walters, P. J. (1975) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-197510000-00031 · Cited by 240
Association of patterns of labial salivary gland inflammation with keratoconjunctivitis SICCA
Daniels, T. E., & Whitcher, J. P. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370615 · Cited by 237
Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections
Hunziker, L., Recher, M., Macpherson, A. J., Ciurea, A., Freigang, S., Hengartner, H., & Zinkernagel, R. M. (2003) · Nature Immunology · doi:10.1038/ni911 · Cited by 233
Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosus
Blomberg, S., Eloranta, M. L., Cederblad, B., Nordlind, K., Alm, G. L., & Rönnblom, L. (2001) · Lupus · doi:10.1191/096120301678416042 · Cited by 230
Self-citationOgawa, N., Ping, L., Zhenjun, L., Takada, Y., & Sugai, S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10577 · Cited by 213
Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice
Braun, D. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(02)00109-9 · Cited by 182
The Combination of Apoptotic U937 Cells and Lupus IgG Is a Potent IFN-α Inducer
Båve, U., Alm, G. V., & Rönnblom, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3519 · Cited by 167
Self-citationApoptosis and Sjögren syndrome
Manganelli, P., & Fietta, P. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2003.50019 · Cited by 158
Cummins, M. J., Papas, A., Kammer, G. M., & Fox, P. C. (2003) · Arthritis Care & Research · doi:10.1002/art.11199 · Cited by 156
Blomberg, S., Eloranta, M., Magnusson, M., Alm, G. V., & Rönnblom, L. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11225 · Cited by 150
Self-citationLevy, D. E., Marié, I., & Prakash, A. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00011-0 · Cited by 143
Role of Natural Interferon-α Producing Cells (Plasmacytoid Dendritic Cells) in Autoimmunity
Rönnblom, L., Eloranta, M., & Alm, G. V. (2003) · Autoimmunity · doi:10.1080/08916930310001602128 · Cited by 137
Self-citationNatural Interferon-α Producing Cells: The Plasmacytoid Dendritic Cells
Fitzgerald-Bocarsly, P. A. (2002) · BioTechniques · doi:10.2144/oct0203 · Cited by 119
Contrasting requirements for ubiquitylation during Fc receptor‐mediated endocytosis and phagocytosis
Booth, J. W., Kim, M.-K., Jankowski, A. W., Schreiber, A. D., & Grinstein, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.251 · Cited by 93
Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases
Stewart, T. A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00088-6 · Cited by 86
Role of viruses in systemic lupus erythematosus and Sjögren syndrome
James, J. A., Harley, J. B., & Scofield, R. H. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00005 · Cited by 78
Induction of Fas Ligand-Mediated Apoptosis by Interferon-α
Kirou, K. A., Krishna, R., Maria, V., Butler, J., & Crow, M. K. (2000) · Clinical Immunology · doi:10.1006/clim.2000.4866 · Cited by 64
Cited by
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Plasmacytoid Dendritic Cells: Recent Progress and Open Questions
Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L., & Sisirak, V. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101345 · Cited by 619
Gottenberg, J.-E., Cagnard, N., Lucchesi, C., Letourneur, F., Mistou, S., Lazure, T., Jacques, S., Ba, N., Ittah, M., Lepajolec, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510837103 · Cited by 611
Immunopathogenic mechanisms of systemic autoimmune disease
Wahren-Herlenius, M., & Dörner, T. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60954-x · Cited by 593
Dendritic cells and cytokines in human inflammatory and autoimmune diseases
BLANCO, P., PALUCKA, A., PASCUAL, V, & BANCHEREAU, J. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.004 · Cited by 566
Metadata
- Authors
- Båve, U., Nordmark, G., Lövgren, T., Rönnelid, J., Cajander, S., Eloranta, M., Alm, G. V., & Rönnblom, L.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-04
- Volume
- 52
- Issue
- 4
- Pages
- 1185-1195
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2071830659
- Cited by
- 390
- References
- 44
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.